After surgery, the SNB, ANB, AOBO, BNP, PGNP, SNPM and OJ measurements underwent significant changes, which influenced the magnitude of mandibular advancement (Tables 2 and 4).
The data showed that the SNA, ISNA, IS-NA, IINB, II-NB, OB, ANP, ISSN, IIPM, SNPP and SNPM (Table 3) had constant mean values and did not change significantly throughout stages t1 to t3; during this period the measurement values significantly increased for the SNB, BNP and PGNP, and decreased for the AOBO, ANB and OJ.
The dental and skeletal changes due to pre-surgical orthodontic treatment were variable; surgical treatment caused significant skeletal changes, especially in the SNB, BNP, PGNP and SNPM measurements (directly related to the mandible), as well as in those indirectly related to it (ANB, AOBO and OJ); dental inclinations were variable and did not affect the magnitude of the mandibular advancement; and SNPM, ANB, ANP and OB were the variables which most significantly influenced the magnitude of the mandibular advancement.
AOBO entered into a letter of intent with HQPL on May 1, 2005 to record AOBO's intention to acquire HQPL.
Tony (Shujun) Liu, Chief Executive Officer of AOBO, said, "AOBO's acquisition of HQPL will enable AOBO to penetrate the wholesale and retail pharmaceutical market.
With its own wholesale and retail network, AOBO can directly market its products.
AOBO appointed Min Jun, vice president and director of AOBO, as general manager of HSPL to oversee production, finance, technology, and sales and marketing of the acquired enterprise.
AOBO acquired 100 percent equity ownership of HSPL including all manufacturing assets, facilities, equipment, land and land use rights, raw materials, inventories, intellectual properties and technical talents on September 9, 2004.